CIK 0001411690 · Non-accelerated filer<br>Smaller reporting company
Bionano Genomics, Inc.
Sign in to watch- Ticker
- BNGO
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 261756290
- Phone
- (858) 888-7600
- Business address
- 9540 TOWNE CENTRE DRIVE, SUITE 100, SAN DIEGO, CA, 92121
- Former names
- BioNano Genomics, Inc, Bionano Genomics, Inc, BioNanomatrix Inc
- Open-market buys, last 90 days
- $9,705
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$9,705. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-04 | Luderer Albert Interim Chief Executive | Purchase | +4,000 | $1.21 | $5K | 8,000 |
| 2026-08-21 | Luderer Albert Interim Chief Executive | Purchase | +4,000 | $1.22 | $5K | 4,000 |
| 2026-08-03 | Hastie Alex Reid Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +54,000 | 54,000 | ||
| 2026-08-03 | Adamchak Mark Principal Accounting Officer | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2026-08-03 | Dixon Jonathan V. General Counsel | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2026-08-03 | OLDAKOWSKI MARK Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2026-06-03 | Adamchak Mark Principal Accounting Officer | Shares withheld for taxes | −7 | $1.30 | $9 | 253 |
| 2026-06-03 | Dixon Jonathan V. GENERAL COUNSEL | Shares withheld for taxes | −24 | $1.30 | $31 | 239 |
| 2026-06-03 | Chaubey Alka CHIEF MEDICAL OFFICER | Shares withheld for taxes | −24 | $1.30 | $31 | 620 |
| 2026-06-03 | OLDAKOWSKI MARK CHIEF OPERATING OFFICER | Shares withheld for taxes | −27 | $1.30 | $35 | 868 |
| 2026-05-14 | Rajkovic Aleksandar Director | Grant or award · Stock Option (Right to Buy) | +9,149 | 9,149 | ||
| 2026-05-14 | Linney Yvonne Director | Grant or award · Stock Option (Right to Buy) | +9,149 | 9,149 | ||
| 2026-05-14 | Vuori Kristiina MD Director | Grant or award · Stock Option (Right to Buy) | +9,149 | 9,149 | ||
| 2026-05-14 | TWOMEY CHRISTOPHER J Director | Grant or award · Stock Option (Right to Buy) | +9,149 | 9,149 | ||
| 2026-05-14 | BARKER DAVID L Director | Grant or award · Stock Option (Right to Buy) | +9,149 | 9,149 | ||
| 2026-02-17 | Adamchak Mark Principal Accounting Officer | Shares withheld for taxes | −3 | $1.10 | $3 | 260 |
| 2026-02-17 | Dixon Jonathan V. GENERAL COUNSEL | Shares withheld for taxes | −6 | $1.10 | $7 | 263 |
| 2026-02-17 | Chaubey Alka CHIEF MEDICAL OFFICER | Shares withheld for taxes | −18 | $1.10 | $20 | 644 |
| 2026-02-17 | OLDAKOWSKI MARK CHIEF OPERATING OFFICER | Shares withheld for taxes | −20 | $1.10 | $22 | 895 |
| 2026-02-17 | Holmlin R. Erik PRESIDENT AND CEO | Shares withheld for taxes | −51 | $1.10 | $56 | 1,657 |
Page 1 of 14 · 266 trades